Lilrincan 40mg Injection
Marketer
Eli Lilly and Company India Pvt Ltd
Salt Composition
Irinotecan (40mg)
Overview Lilrincan 40mg Injection
Oncolyn 40mg Injection treats colorectal cancer by inhibiting or retarding cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your individual needs and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include weariness, nausea, emesis, debility, and alopecia. This medication can suppress blood cell production (red and white blood cells), increasing infection risk. Report fever, pharyngitis, or persistent diarrhea immediately. Regular blood tests monitor blood cell counts, as well as cardiac, hepatic, and uric acid levels. Prior to treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, and all medications, especially anti-infectives, as interactions are possible. This injection is contraindicated during pregnancy and lactation; reliable contraception is essential for both partners throughout the treatment period.
Uses of Lilrincan 40mg Injection
Colorectal cancer
Major Benefits of Lilrincan 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Lilrincan 40mg Injection:
- Fatigue
- Nausea
- Vomiting
- Weakness
- Hair loss
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Decreased appetite
- Mucosal inflammation
How to use Lilrincan 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Lilrincan 40mg Injection works:
The injectable drug Lilrincan, 40mg, combats cancer by inhibiting topoisomerase I, a crucial enzyme in cancer cell DNA replication. This action restricts cancerous cell proliferation, ultimately leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Consuming alcohol while using Lilrincan 40mg Injection may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administration of Lilrincan 40mg Injection is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician may prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Lilrincan 40mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant harm from the medication.
DrivingUNSAFE
The administration of Lilrincan 40mg Injection can potentially reduce alertness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects manifest.
KidneySAFE IF PRESCRIBED
The use of Lilrincan 40mg Injection in individuals with kidney impairment is likely safe, with current evidence indicating dose modification may be unnecessary. However, physician consultation is advised. This medication is contraindicated for patients undergoing dialysis.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Lilrincan 40mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Lilrincan 40mg Injection :
Forgetting a dose of Lilrincan 40mg Injection? Seek medical advice immediately.
Facts to Know About Lilrincan 40mg Injection
| Label | Value |
|---|---|
| Chemical Type | Camptothecin Analog |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | DNA Topoisomerase Inhibitor |
3,018 People bought this recently